Alterations in homologous recombination repair genes and impact on survival among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing

Detection of homologous recombination repair (HRR) deficiency in pancreatic ductal adenocarcinoma (PDAC) is advancing, yet germline HRR mutation landscapes and survival impact remain poorly characterized in Chinese patients. In this study, we undertook next-generation sequencing among 126 Chinese PDAC patients using a 32-gene panel. Pathogenic and likely pathogenic (P/LP) germline mutations were diagnosed according to the ACMG variant classification categories. Mutation frequencies of HRR-related genes were analyzed statistically, and hotspot genes with high mutation prevalence were identified. Simultaneously, we compared the differences in demographic information, tumor characteristics, and clinical outcomes between P/LP mutation carriers and non-carriers. Germline P/LP variants were identified in 11.1% of the 126 patients, most frequently involving ATM and BRCA2. VUS were detected in 31.7% of patients, with ATM, BRCA2, and BRIP1 being the most commonly involved genes. Survival analysis of 103 patients showed longer overall survival in carriers of germline P/LP variants than in non-carriers ( P = 0.032). In the platinum-treated subgroup ( n = 20), overall survival was numerically longer in P/LP variant carriers than in non-carriers, but the difference was not statistically significant. SMAD4 loss was associated with shorter survival in the 39 patients with complete pathological data. These findings characterize the distribution of germline HRR variants in this cohort and suggest an association between P/LP variants and overall survival that warrants confirmation in larger prospective studies.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-18
DOI
https://doi.org/10.1038/s41598-026-80451-y
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Alterations in homologous recombination repair genes and impact on survival among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing

Nan Duan, Qian Ma, Bo Jin, Le Wang et al.
2 links
Scientific Reports
Pancreatic and Hepatic Oncology Research
article

Alterations in homologous recombination repair genes and impact on survival among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing

Nan Duan, Qian Ma, Bo Jin, Le Wang, Haixia Li, Jialin Du, Yongsu Ma, Yu Zhu
article en

Abstract

Detection of homologous recombination repair (HRR) deficiency in pancreatic ductal adenocarcinoma (PDAC) is advancing, yet germline HRR mutation landscapes and survival impact remain poorly characterized in Chinese patients. In this study, we undertook next-generation sequencing among 126 Chinese PDAC patients using a 32-gene panel. Pathogenic and likely pathogenic (P/LP) germline mutations were diagnosed according to the ACMG variant classification categories. Mutation frequencies of HRR-related genes were analyzed statistically, and hotspot genes with high mutation prevalence were identified. Simultaneously, we compared the differences in demographic information, tumor characteristics, and clinical outcomes between P/LP mutation carriers and non-carriers. Germline P/LP variants were identified in 11.1% of the 126 patients, most frequently involving ATM and BRCA2. VUS were detected in 31.7% of patients, with ATM, BRCA2, and BRIP1 being the most commonly involved genes. Survival analysis of 103 patients showed longer overall survival in carriers of germline P/LP variants than in non-carriers ( P = 0.032). In the platinum-treated subgroup ( n = 20), overall survival was numerically longer in P/LP variant carriers than in non-carriers, but the difference was not statistically significant. SMAD4 loss was associated with shorter survival in the 39 patients with complete pathological data. These findings characterize the distribution of germline HRR variants in this cohort and suggest an association between P/LP variants and overall survival that warrants confirmation in larger prospective studies.

Scientific Reports
Peking University (CN), Peking University First Hospital (CN)
Peking University First Hospital, National Natural Science Foundation of China
Good health and well-being
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon